← back to search

Tiefeng Shi

Harbin Medical University · CN
Area of research
Physiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cancer research, Thyroid cancer, microRNA, Biology, Medicine, and Downregulation and upregulation.
h-index
citations
140
works
11
NIH funding
primary concept
email

Recent publications

APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration
Frontiers in Oncology 2025cited by 1position: lastdoi
Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes
International Journal of Biological Macromolecules 2024cited by 4position: middledoi
Contrast-enhanced ultrasound combined with percutaneous ultrasound-guide core needle biopsies in the diagnosis of pancreatic lesions: a propensity score-matched study
BMC Cancer 2024cited by 1position: middledoi
Ultrasound radiomics models based on multimodal imaging feature fusion of papillary thyroid carcinoma for predicting central lymph node metastasis
Frontiers in Oncology 2023cited by 11position: middledoi
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
Bioengineered 2022cited by 8position: middledoi
RETRACTED ARTICLE: Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression
Cell Cycle 2020cited by 23position: middledoi
<p>Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2</p>
OncoTargets and Therapy 2020cited by 19position: lastdoi
MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma
Biomedicine & Pharmacotherapy 2018cited by 27position: middledoi
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
OncoTargets and Therapy 2017cited by 34position: middledoi
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for Modulating Pain-evoked Activities of Neurons in the Hippocampal CA3 Region of Rats
CNS & Neurological Disorders - Drug Targets 2016cited by 6position: middledoi
Modulatory role of glutamic acid on the electrical activities of pain-related neurons in the hippocampal CA3 region
Neuroscience Letters 2012cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huadong Qin · Harbin Medical University4 papers (2017–2020)Quan Dai · Harbin Medical University2 papers (2023–2024)Man Ying Xu · Harbin Medical University2 papers (2012–2016)Yao Liu · Hebei Medical University2 papers (2017–2020)Chunxiao Yang · The First Affiliated Hospital, Sun Yat-sen University2 papers (2012–2016)Chenlei Shi · Harbin Medical University2 papers (2018–2024)Yanfei Ma · Harbin Medical University2 papers (2020–2020)Xingru Tao · Harbin Medical University1 papers (2024–2024)Yue Yang · State Ethnic Affairs Commission1 papers (2012–2012)Man Lu · Zhejiang Chinese Medical University1 papers (2023–2023)Chao Ding · Suizhou Central Hospital1 papers (2018–2018)Tao Yi · Harbin Medical University1 papers (2023–2023)Jianting Man · Harbin Medical University1 papers (2022–2022)Meiyue Song · Harbin Medical University1 papers (2020–2020)Xiaoping Leng · Ministry of Education of the People's Republic of China1 papers (2023–2023)Yingming Liu · Shandong University of Technology1 papers (2024–2024)Jinshun Xu · Dalian Medical University1 papers (2023–2023)Yu Sun · Fudan University1 papers (2020–2020)Xiaobo Wu · Fujian Medical University1 papers (2024–2024)Xiaoyu Lu · Central South University of Forestry and Technology1 papers (2012–2012)